CAMP4 Therapeutics Corporation
CAMP · NASDAQ
12/31/2024 | 12/31/2023 | 11/30/2023 | 2/28/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$52 | -$49 | – | -$44 |
| Dep. & Amort. | $2 | $2 | – | $1 |
| Deferred Tax | $0 | $0 | – | $0 |
| Stock-Based Comp. | $4 | $3 | – | $1 |
| Change in WC | -$2 | -$0 | – | $0 |
| Other Non-Cash | $2 | $1 | – | $3 |
| Operating Cash Flow | -$46 | -$44 | – | -$39 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | – | -$4 |
| Net Acquisitions | $0 | $0 | – | $0 |
| Inv. Purchases | $0 | $0 | – | $0 |
| Inv. Sales/Matur. | $0 | $0 | – | $0 |
| Other Inv. Act. | $0 | $0 | – | $0 |
| Investing Cash Flow | -$0 | -$1 | – | -$4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | $0 | – | -$0 |
| Stock Issued | $0 | $0 | – | $0 |
| Stock Repurch. | $0 | $0 | – | $0 |
| Dividends Paid | $0 | $0 | – | $0 |
| Other Fin. Act. | $72 | $0 | – | $100 |
| Financing Cash Flow | $72 | $0 | – | $100 |
| Forex Effect | $0 | $0 | – | $26 |
| Net Chg. in Cash | $26 | -$45 | – | $83 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $40 | $85 | – | $27 |
| End Cash | $66 | $40 | – | $110 |
| Free Cash Flow | -$46 | -$45 | – | -$43 |